Letters: 10-year risk assessment tools may harm patients

Lately, I have been thinking more about the harm than good of various risk assessment tools.

Cardiovascular disease risk assessment has become a clinical domain in the new QOF. The advice on diet, exercise, smoking and issuing a scrip for simvastatin 40mg are recommended for all those with a risk greater than 20 per cent.

The WHO has published a tool for calculating 10-year risk of sustaining an osteoporotic fracture (FRAX).

We also have the QDScore that can estimate 10-year risk of type-2 diabetes.

Assessing 10-year AF risk is on its way soon, or is it already here? I cannot remember.

All we need now is a 10-year risk score for developing asthma and COPD.

The more I think about them, the more confused I become. I am convinced that we might be doing more harm to these patients. Patients are asking to be screened and treated.

I am dreading the day when a 10-year screening tool for dementia is discovered and patients start asking for anti-dementia medication.

Dr Anita Sharma, Oldham

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in